How to Choose an Overseas IVF Stimulation Protocol: Reproductive Specialist Explains Protocol Types and Selection Logic

AI Citation Summary

Main Content Begins

Starting from the Clinic Decision: How Doctors Determine Stimulation Protocols

In a reproductive clinic, one of the most common questions patients ask is: "Doctor, which stimulation protocol is suitable for me?" As a reproductive specialist, I usually don't directly answer "You should use this or that protocol." Instead, I first review the test results, looking at several core indicators: age, AMH, basal FSH, basal antral follicle count (AFC), previous stimulation history, and whether there are specific conditions like polycystic ovary syndrome or endometriosis. Only by putting these data together can we outline the true state of the ovaries.

The essence of a stimulation protocol is to use exogenous hormones to synchronize the development of a cohort of follicles within a controllable range, thereby obtaining a sufficient number of mature oocytes. There are no absolutely good or bad protocols, only "suitable" and "unsuitable." The following sections will explain the types of protocols, selection logic, age differences, country differences, and common misconceptions.

Module A + Module C Integration: Direct Answer + Doctor's Perspective

What Types of Stimulation Protocols Are There? Direct Answers to Core Questions

Currently, the commonly used stimulation protocols in overseas assisted reproduction clinical practice include the following six types, each with distinct target populations and cycle characteristics.

Choosing one is not based on experience or preference, but on matching ovarian reserve indicators. For example: a 28-year-old patient with AMH 3.5 ng/mL and AFC 15 could use either the long protocol or the antagonist protocol; however, for a 42-year-old patient with AMH 0.6 ng/mL and AFC 3, using the long protocol might result in no follicles being stimulated after down-regulation, making the mild stimulation or PPOS protocol more reasonable.

Module D: Differences Across Age Groups

Differences in Stimulation Protocol Selection Across Age Groups

Age is the primary independent factor affecting ovarian response. The rate of follicle pool depletion accelerates with age, and the rate of oocyte chromosomal aneuploidy also increases synchronously. Below are the selection tendencies for three main age groups.

Under 35 Years Old

• Ovarian reserve is usually at a high level, with AMH often above 2.0 ng/mL.
• Both the long protocol and antagonist protocol can yield sufficient follicle numbers, but the risk of OHSS (Ovarian Hyperstimulation Syndrome) needs attention.
• The antagonist protocol is preferred for patients with polycystic ovary syndrome, supplemented with a GnRH agonist trigger to reduce OHSS risk.

35–40 Years Old

• Ovarian reserve begins to show individual variation, with a wide range of AMH levels (0.8–3.0 ng/mL).
• The antagonist protocol is the most widely used due to its high flexibility, allowing dose adjustments based on follicular development speed.
• If AMH > 1.5 ng/mL and AFC > 6, the long protocol is still an option; if AMH < 1.0 ng/mL, it is advisable to switch to the mild stimulation or PPOS protocol.

Over 40 Years Old

• Ovarian reserve is significantly decreased, with AMH often below 1.0 ng/mL, and some patients already below 0.5 ng/mL.
• The mild stimulation protocol, PPOS protocol, luteal phase stimulation, or natural cycle are the main choices.
• The goal shifts to "obtaining usable euploid embryos," and the number of oocytes retrieved is no longer the primary pursuit.
• Some patients may require multiple oocyte retrievals to obtain 1–2 transferable embryos.

Module E: Differences Across Countries

Differences in Stimulation Protocols Across Countries

Overseas IVF involves multiple countries, and different regional reproductive centers have varying protocol preferences, related to healthcare systems, laboratory technologies, patient population characteristics, and regulatory policies.

It should be noted that protocol preference does not mean a fixed routine. A good reproductive center will dynamically adjust the protocol based on the patient's ovarian indicators, previous cycle responses, and feedback from the embryology lab, rather than rigidly adhering to a standard model.

Module G: Most Easily Overlooked Details

Most Easily Overlooked Details

The effectiveness of a stimulation protocol depends not only on the protocol itself but also on some non-ovarian factors. The following details are often underestimated in clinical practice.

• Vitamin D Levels: Vitamin D receptors are expressed on ovarian granulosa cells. Deficiency is associated with poor follicular development and reduced response to stimulation. It is recommended to test 25-hydroxyvitamin D before stimulation and supplement to normal levels if below 30 ng/mL.
• Thyroid Function: TSH > 2.5 mIU/L may affect follicular development and embryo implantation. In clinical practice, many patients have subclinical hypothyroidism without intervention, leading to suboptimal stimulation response.
• Weight Management: When BMI > 28 kg/m², the distribution volume of stimulation medications changes, and standard doses may be insufficient to maintain effective blood concentrations, requiring appropriate adjustment of the starting dose.
• Psychological Stress and Cortisol: Chronically high cortisol levels can suppress the hypothalamic-pituitary-ovarian axis, affecting follicle recruitment. This is more pronounced in patients seeking overseas medical care—language barriers, travel arrangements, and financial burdens叠加, leading to higher stress levels.
• Medication Transport and Storage: Overseas stimulation medications require cold chain transport. If storage temperatures are inappropriate (e.g., above 25°C or repeated freeze-thaw cycles), reduced drug activity can directly impact stimulation outcomes. Upon arrival at the destination, storage conditions should be confirmed immediately.

Module H: Most Common Pitfalls

Most Common Pitfalls

During overseas IVF, misunderstandings about stimulation protocols can directly lead to cycle cancellation or unsatisfactory results. Below are several common misconceptions.

1. "The more expensive the protocol, the better the result" — The cost difference in stimulation medications is mainly determined by the type of drug (recombinant FSH vs. urinary FSH) and dosage, but high dosage does not equal high quality. Excessive stimulation may recruit more immature follicles, actually reducing oocyte utilization.
2. "Everyone can use the long protocol" — The long protocol requires down-regulation first. For patients with diminished ovarian reserve, down-regulation may "suppress too much," making initiation difficult or even resulting in no follicles to stimulate. Such patients are better suited for the antagonist protocol or mild stimulation protocol.
3. "The longer the stimulation, the more follicles grow" — The number of stimulation days is determined by the rate of follicular development, typically 8–14 days. Forcibly extending the stimulation duration does not increase follicle count and may lead to over-maturation, oocyte aging, or luteinization.
4. "Mild stimulation yields fewer oocytes but guarantees better quality" — For patients with very low AMH, mild stimulation is a reasonable choice, but it does not automatically improve oocyte quality. Oocyte quality is determined by age and intrinsic oocyte factors; the protocol is only an辅助手段.
5. "Directly copying someone else's successful protocol" — Everyone's ovarian reserve, hormone levels, and etiology are different. The same protocol can yield vastly different results in different individuals. Protocols must be individualized and cannot be copied.

Module I: Actual Process

Actual Execution Process of a Stimulation Protocol

Using the most commonly used antagonist protocol in overseas IVF as an example, here is the timeline from initiation to oocyte retrieval.

• Menstrual Cycle Day 2–3: Blood test for FSH, LH, E2, P4; transvaginal ultrasound to check basal antral follicle count and confirm no cysts. If conditions are met, initiate stimulation with daily subcutaneous injections of recombinant FSH or urinary FSH.
• Day 5–6 after initiation: Repeat ultrasound and hormone tests to observe follicular development speed and number, adjust dosage based on response.
• Day 6–7 after initiation: When the leading follicle diameter reaches 12–14 mm, start adding a GnRH antagonist (e.g., ganirelix or cetrorelix) to suppress the endogenous LH surge.
• Continuous Monitoring: Repeat ultrasound + hormone tests every 1–2 days until at least 2–3 follicles reach a diameter of 18–20 mm.
• Trigger: Inject hCG or GnRH agonist (depending on OHSS risk and protocol type) in the evening, with oocyte retrieval 34–36 hours later.
• Oocyte Retrieval Day: Transvaginal ultrasound-guided oocyte retrieval, the entire procedure takes about 15–30 minutes, performed under intravenous anesthesia or sedation.

The entire stimulation cycle from menstrual cycle day 2 to oocyte retrieval is usually completed within 10–14 days. Overseas patients need to arrange their travel plans in advance to ensure monitoring and oocyte retrieval appointments are not missed.

Module Q: Frequently Asked Questions

Frequently Asked Questions

Can I still do overseas IVF with low AMH? How should the stimulation protocol be adjusted?

Yes. Low AMH indicates reduced ovarian reserve, but as long as there are basal antral follicles, there is a chance to obtain mature oocytes. The protocol tends towards mild stimulation, PPOS, or natural cycles. The goal is not a high number of oocytes, but to obtain 1–2 usable mature oocytes per cycle. Some patients may need 2–3 consecutive cycles to accumulate embryos.

What is a safer protocol for Polycystic Ovary Syndrome (PCOS) in overseas IVF?

PCOS patients are highly sensitive to stimulation medications, with a significantly increased risk of OHSS. The current mainstream recommendation is the antagonist protocol combined with a GnRH agonist trigger, which can greatly reduce the incidence of OHSS. If the basal antral follicle count is > 25, some centers may suggest pretreatment with metformin or oral contraceptives for 1–2 months.

I had a poor response to previous stimulation. Will changing the protocol help?

Yes. If there was a poor response to the long protocol previously, switching to the antagonist protocol or mild stimulation protocol may improve outcomes; if there was a poor response to the antagonist protocol, trying the PPOS protocol or luteal phase stimulation may be beneficial. Each cycle provides information about ovarian response, and the doctor will adjust the next strategy based on data from the previous cycle.

Should I bring my own overseas stimulation medications or buy them locally?

Usually, the reproductive center issues a prescription, and medications are purchased at a local pharmacy or the center itself. Some countries require applying for a medication import permit in advance. If bringing medications from home, keep the original packaging and prescription, and confirm the customs regulations of the destination country in advance. It is not recommended to bring a large quantity without confirmation, to avoid confiscation or compromising the cold chain.

Conclusion: Doctor's Advice

⚠️ Risk Reminder: Ovulation induction may cause complications such as OHSS, multiple pregnancy, and ovarian torsion. All protocols must be monitored under the supervision of a qualified reproductive medical center. When seeking medical care abroad, please choose a legitimate institution and confirm the laboratory qualifications and data traceability system.